Roche will invest $50 billion in American manufacturing over the next five years, including building a new facility somewhere in Indiana.The Swiss biotech company said the investment will ...

The move is part of Roche’s previously announced plan to invest $50 billion in pharmaceuticals and diagnostics over the next five years in the United States. Roche Diagnostics, with its North America ...

Roche said Indiana would receive a new manufacturing facility for continuous glucose monitoring. A specific location was not disclosed. It also said “significant” expansions and upgrades were ...

More: Roche pours $50 billion into U.S. manufacturing; at least one new plant will be in Indiana Roche Diagnostics solidified its North American headquarters in Indianapolis in 1998 and has ...

Roche, a Swiss company, will develop a new manufacturing facility for continuous glucose monitoring in Indiana. Funds will also go to upgrades and an expansion to the existing pharmaceutical and ...

Roche Diagnostics announced it plans to invest up to $550 million in its Diagnostics site in Indianapolis by 2030.

Indiana, Massachusetts and Pennsylvania. Some of the $50 billion in investments were already underway or planned for the next several years, Roche spokesperson Rebekka Schnell said in an e-mail, ...

Roche will invest up to $550 million in its Indianapolis diagnostics site by 2030 to expand production of its continuous glucose monitoring systems. The Indianapolis location serves as the ...

Basel, Switzerland-based Roche said in April that it had committed to $50 billion in U.S. investment over the next five years, including new and expanded manufacturing facilities in Indiana ...